Modern treatment options such as radiotherapy dose intensification (EBRT boost, brachytherapy or Papillon technique) or additional chemotherapy in total neoadjuvant therapy for rectal cancers have been shown to improve rectal preservation rates better than ever before.

The management of Hepatocellular Carcinoma (HCC) should be conducted in a multidisciplinary setting to offer individualized therapy. Most patients with HCC are not candidates for curative treatments because of tumor extent or underlying liver dysfunction.

The contouring activity focuses on MR-guided radiation therapy contouring techniques tailored specifically for pancreatic cancer stereotactic body radiation therapy (SBRT). This activity reviews MR imaging to delineate target volumes and critical structures with precision.

Anal cancer rates are increasing, and there is a need to improve coordination across the spectrum of anal cancer care, from diagnosis, treatment, recovery and survivorship. Failure to understand the roles of all the multidisciplinary aspects of care leads to suboptimal patient care.  

The educational activity focuses on MR-guided radiation therapy contouring techniques tailored specifically for pancreatic cancer stereotactic body radiation therapy (SBRT).

It is difficult to know when to strongly advocate for radiation therapy in many GI malignancies.

This session highlights the most clinically relevant abstracts within the Gastrointestinal Cancer track of the 2023 ASTRO Annual Meeting scientific program.

The field of cancer is a rapidly evolving field with new treatment approaches moving to clinic on a daily basis. Radiation Oncology is no different. It is extremely difficult for a practicing clinician to stay abreast of new developments in cancer care.

The associated article is a meta-analysis reviewing published studies for SBRT for HCC with 5+ years of outcome data. 19 studies were identified that met the criteria. The article reviews those 19 studies and makes recommendations for appropriate SBRT for HCC.